Doxorubicin mediated cardiotoxicity in rats: Protective role of felodipine on cardiac indices

Environmental Toxicology and Pharmacology

Volumn 36, Issue 3, 2013, Pages 787-795

  Gandhi, Hardik ^a   Patel, Vaibhav B ^a,b   Mistry, Nirav ^a   Patni, Naeem ^a   Nandania, Jatin ^a   Balaraman, Ramachandran ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ATPase; Cardiotoxic agents; Caspase 3; Doxorubicin; ECG; Felodipine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CASPASE 3; CREATINE KINASE MB; DOXORUBICIN; FELODIPINE; LACTATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMICAL COMPOSITION; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; GRAVIMETRY; HEART HEMODYNAMICS; HEART INDEX; HEART PROTECTION; HEART WEIGHT; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RAT; RR INTERVAL; ST SEGMENT;

ATPASE; CARDIOTOXIC AGENTS; CASPASE-3; DOXORUBICIN; ECG; FELODIPINE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; CASPASES; CREATINE KINASE, MB FORM; DOXORUBICIN; ELECTROCARDIOGRAPHY; FELODIPINE; GLUTATHIONE; HEART DISEASES; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84883024211     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.07.007     Document Type: Article

References (57)

1. Aluise C.D., Miriyala S., Noel T., Sultana R., Jungsuwadee P., Taylor T.J., Cai J., et al. 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology & Medicine 2011, 50:1630-1638.
2. Andrieu-Abadi N., Jaffrezou J.P., Hatem S., Laurent G., Levade T., Mercadier J.J. l-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB Journal 1999, 13:1501-1510.
3. Arai M., Yoguchi A., Takizawa T., Yokoyama T., Kanda T., Kurabayashi M., et al. Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription. Circulation Research 2000, 86:8-14.
4. Arola O.J., Saraste A., Pulkki K., Kallajoki M., Parvinen M., Voipio-Pulkki L.M. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Research 2000, 60:1789-1792.
5. Balli E., Mete U.O., Tuli A., Tap O., Kaya M. Effect of melatonin on the cardiotoxicity of doxorubicin. Histology and Histopathology 2004, 19:1101-1108.
6. Bast A., Haenen G.R., Bruynzeel A.M., Van der Vijgh W.J. Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials. Cardiovascular Toxicology 2007, 7:154-159.
7. Bielawska A.E., Shapiro J.P., Jiang L., Melkonyan H.S., Piot C., Wolfe C.L., et al. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. American Journal of Pathology 1997, 151:1257-1263.
8. Bonting S.L. Sodium-potassium activated adenosinetriphosphatase and cation transport. Membranes and Ion Transport 1970, 25-28. Wiley-Interscience, London. E.E. Bittar (Ed.).
9. Chatterjee K., Zhang J., Honbo N., Karliner J.S. Cardiology 2010, 115:155-162.
10. Colak M.C., Parlakpinar H., Tasdemir S., Samdanci E., Kose E., Polat A., et al. Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat. Human and Experimental Toxicology 2012, 31:945-954.
11. Cruden N., Fox K. Current approaches to the management of stable angina. Prescriber 2011, 22:22-38.
12. Das J., Ghosh J., Manna P., Sil P.C. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochemical Pharmacology 2011, 81:891-909.
13. den Hartog G.J., Haenen G.R., Boven E., wan der Vijgh W.J., Bast A. Lecithinized copper, zinc-superoxide dismutase as a protector against doxorubicin-induced cardiotoxicity in mice. Toxicology and Applied Pharmacology 2004, 194:180-188.
14. Ding Y., Vaziri N.D. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 1998, 32:718-723.
15. Edraki N., Mehdipour A.R., Khoshneviszadeh M., Miri R. Dihydropyridines: evaluation of their current and future pharmacological applications. Drug Discovery Today 2009, 14:1058-1066.
16. Elliot W.J., Ram C.V.S. Calcium channel blockers. Journal of Clinical Hypertension 2011, 13:687-689.
17. Farvin K.H.S., Anandan R., Kumar S.H., Shiny K.S., Sankar T.V., Thankappan T.K. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacological Research 2004, 50:231-236.
18. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. Journal of Biological Chemistry 1925, 66:375-400.
19. Haga Y., Hatori N., Nordlander M., Nordlander R., Sioquist P.O., Ryden L. Coronary venous retroperfusion of felodipine reducing infarct size without affecting regional myocardial blood flow. European Heart Journal 1993, 14:1386-1393.
20. Hjerten S., Pan H. Purification and characterization of two forms of a low affinity calcium ion-ATPase from erythrocyte membrane. Biochimica et Biophysica Acta 1983, 728:281-288.
21. 24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials 2008, 29:3451-3460.
22. Janero D.R., Burghardt B. Antiperoxidant effects of dihydropyridine calcium antagonists. Biochemical Pharmacology 1989, 38:4344-4348.
23. Jang M.K., Kendaiah S., Drew B., Phillips T., Selman C., Julian D., et al. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Letters 2004, 577:483-490.
24. Jiang B., Zhang L., Li M., Wu W., Yang M., Wang J., et al. Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress. Food and Chemical Toxicology 2008, 46:1510-1515.
25. Kalivendi S.V., Konorev E.A., Cunningham S., Vanamala S.K., Kaji E.H., Joseph J., et al. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochemical Journal 2005, 389:527-539.
26. Karim S., Bhandari U., Kumar H., Salam A., Siddiqui M.A.A., Pillai K.K. Doxorubicin induced cardiotoxicity and its modulation by drugs. International Journal of Pharmaceutics 2001, 33:203-207.
27. Kelishomi R.B., Ejtemaeemehr S., Tavangar S.M., Rahimian R., Mobarakeh J.I., Dehpour A.R. Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology 2008, 243:96-104.
28. Krown K.A., Trevor P.M., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. Journal of Clinical Investigation 1996, 98:2854-2865.
29. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. Journal of Experimental Medicine 1997, 185:1481-1486.
30. Liu X., Chua C.C., Gao J., Chen Z., Landy C.L.C., Hamdy R., et al. Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. American Journal of Physiology - Heart and Circulatory Physiology 2004, 286:H933-H939.
31. Lowry O.H., Rosenbrough N.J., Farr A.I., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
32. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 1979, 528:67-78.
33. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 1977, 197:165-167.
34. Nayer W.G., Ferrari R., Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfusion myocardium. American Journal of Cardiology 1980, 46:242-248.
35. 2+-ATPase activity by menadione metabolism and its restoration by thiols. FEBS Letters 1985, 149:153.
36. O'Brien C.E., Harik N., James L.P., Seib P.M., Stowe C.D. Cesium-induced QT-interval prolongation in an adolescent. Pharmacotherapy 2008, 28:1059-1065.
37. Ohinishi T., Suzuki T., Suzuki Y., Ozawa K. A comparative study of plasma membrane magnesium ion ATPase activity in normal, regenerating and malignant cells. Biochimica et Biophysica Acta 1982, 684:67-74.
38. +-ATPase in gerbil cerebral cortex following ischemia. Journal of Neuroscience Research 1988, 19:252-257.
39. Paranka N.S., Dorr R.T. Effect of doxorubicin on glutathione and glutathione dependent enzymes in cultured rat heart cells. Anticancer Research 1994, 14:2047-2052.
40. Park S. Effect of Calcium Channel Blockers on the Na+/K+-ATPase α Isoform Expression in Cultured Aortic Smooth Muscle Cells 1996, Louisiana State University, New Orleans, Louisiana, (dissertation).
41. Patel V., Upaganlawar A., Zalawadia R., Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. European Journal of Pharmacology 2010, 644:160-168.
42. Quiles J.L., Huertas J.R., Battino M., Mataix J., Ramirez-Tortosa M.C. Antioxidant nutrients and adriamycin toxicity. Toxicology 2002, 180:79-95.
43. Richard C., Ghibu S., Delamasure-Chalumeau S., Guilland J.C., Rosiers C.D., Zeller M., et al. Oxidative stress and myocardial gene alterations associated with doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation. Journal of Pharmacology and Experimental Therapeutics 2011, 339:807-814.
44. Singal P.K., Iliskovic N. Doxorubicin induced cardiomyopathy. New England Journal of Medicine 1998, 339:900-905.
45. Slater T.F., Sawyer B.C. The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Biochemical Journal 1971, 123:823-828.
46. Sugawara H., Tobise K., Kikuchi K. Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation. Hypertension Research 1996, 19:223-228.
47. Suliman H.B., Carraway M.S., Ali A.S., Reynolds C.M., Welty-Wolf K.E., Piantadosi C.A. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. Journal of Clinical Investigation 2007, 117:3730-3741.
48. 2 inhbition. Cardiovascular Toxicology 2007, 7:86-91.
49. Tesoriere L., Ciaccio M., Valenza M., Bongiorno A., Maresi E., Albiero R., et al. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality. Journal of Pharmacology and Experimental Therapeutics 1994, 269:430-436.
50. Umansky S.R., Shapiro J.P., Cuenco G.M., Foehr M.W., Bathurst I.C., Tomei L.D. Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion. Cell Death and Differentiation 1997, 4:608-616.
51. Upaganlawar A., Gandhi C., Balaraman R. Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats. Plant Foods for Human Nutrition 2009, 64:75-80.
52. Upasani C.D., Balaraman R. Effect of vitamin E, vitamin C and spirulina on the levels of membrane bound enzymes and lipids in some organs of rats exposed to lead. International Journal of Pharmaceutics 2001, 33:185-191.
53. Wang L., Ma W., Markovich R., Chen J.W., Wang P.H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circulation Research 1998, 83:516-522.
54. Xing S.S., Tan H.W., Bi X.P., Zhong M., Zhang Y., Zhang W. Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats. Molecular Medicine 2008, 14:395-402.
55. Ytrehus K., Liu Y., Tsuchida A., Miura T., Liu G.S., Yang X.M., et al. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. American Journal of Physiology 1994, 267:H2383-H2390.
56. Zhang W., Sun X., Zhao X., Thoren P., Hedner T. Effects of calcium antagonist felodipine on renal sympathetic nerve activity in rats with congestive heart failure. Cardiovascular Drugs and Therapy 1997, 11:645-650.
57. Zuppinger C., Timolati F., Suter T.M. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovascular Toxicology 2007, 7:61-66.